We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...

In trading on Tuesday, shares of Denali Therapeutics Inc (Symbol: DNLI) crossed above their 200 day moving average of $23.11, changing hands as high as $23.33 per share. Denali Therapeutics Inc ...

Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Denali Therapeutics in a research report issued to ...

A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have lost about 21.2% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Fintel reports that on December 16, 2024, Stifel upgraded their outlook for Denali Therapeutics (NasdaqGS:DNLI) from Hold to Buy. As of December 3, 2024, the average one-year price target for ...

Fintel reports that on January 3, 2025, William Blair initiated coverage of Denali Therapeutics (NasdaqGS:DNLI) with a Outperform recommendation. As of December 23, 2024, the average one-year ...

Denali Therapeutics Inc. DNLI announced that the FDA has granted Breakthrough Therapy Designation to its pipeline candidate, tividenofusp alfa (DNL310), for the treatment of individuals with ...

Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day.

The firm increased its portfolio allocation in DNLI by 16.85% over the last quarter. Wellington Management Group Llp holds 10,727K shares representing 7.45% ownership of the company. In its prior ...